StockWatch
·
Refuse Systems
Quarterly ResultAug 6, 2026, 07:46 AM

Deep Isolation Nuclear Q2 Revenue $1.3M; Net Loss $3.0M

AI Summary

Deep Isolation Nuclear, Inc. announced its Q2 2026 financial results, reporting $1.3 million in revenue and a net loss of $3.0 million. The company maintained a cash balance of $19.4 million as of June 30, 2026. Operationally, Deep Isolation achieved significant milestones including surpassing 100 issued patents, establishing a field presence for its deep borehole demonstration program, and its common stock beginning to trade on the OTCQB Venture Market. Additionally, the company was selected as the sole industrial partner on three competitive federal grants from the U.S. Department of Energy.

Key Highlights

  • Reported consolidated revenue of $1.3 million for Q2 2026, down 19% YoY.
  • Reported a net loss of $3.0 million for Q2 2026, compared to $1.36 million net loss in Q2 2025.
  • Had available cash of $19.4 million as of June 30, 2026.
  • Research and development expense increased to $1.2 million in Q2 2026.
  • Selling, general and administrative expenses increased to $2.7 million in Q2 2026.
  • Surpassed 100 issued patents worldwide for nuclear waste disposal technology.
  • Common stock began trading on the OTCQB Venture Market under "DBHL" subsequent to quarter end.
  • Selected as sole industrial partner on three federal grants under U.S. DOE's Project GENESIS.